We are a diverse team of scientific researchers and specialists in drug development at the cutting edge of microbiome exploration, seeking to uncover and create treatments based on the microbiome. The progression from research to the creation of groundbreaking and life-preserving microbiome-based treatments is further strengthened by BiomeBank's collaboration with leading biomedical research institutions worldwide. This encompasses RMIT University, Hudson Institute of Medical Research, and global Hospital Networks.